[HTML][HTML] Risk of post‐thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study
…, MA Crowther, A Perrier, RH White, LM Vickars… - Journal of Thrombosis …, 2012 - Elsevier
… PERRIER 9 , RH WHITE 10 , LM VICKARS 11 , T. RAMSAY 2 , SR KAHN 1 7 … Solymoss,
MA Crowther and LM Vickars performed the research and collected the data. MT Betancourt and …
MA Crowther and LM Vickars performed the research and collected the data. MT Betancourt and …
Supportive care and chelation therapy in MDS: are we saving lives or just lowering iron?
HA Leitch, LM Vickars - ASH Education Program Book, 2009 - ashpublications.org
… Leitch HA, Badawi MA, Chase J, Vickars LM. Red blood cell transfusion independence
following the initiation of iron chelation therapy in myelodysplastic syndrome: a case report and …
following the initiation of iron chelation therapy in myelodysplastic syndrome: a case report and …
Predictors of post‐thrombotic syndrome in a population with a first deep vein thrombosis and no primary venous insufficiency
…, A Perrier, RH White, LM Vickars… - … of Thrombosis and …, 2013 - Wiley Online Library
Background Post‐thrombotic syndrome ( PTS ) is the most frequent complication of deep vein
thrombosis ( DVT ). Its diagnosis is based on clinical characteristics. However, symptoms …
thrombosis ( DVT ). Its diagnosis is based on clinical characteristics. However, symptoms …
Clinical features, treatment, and outcome of HIV‐associated immune thrombocytopenia in the HAART era
…, LM Vickars, CS Leger, LM Foltz… - Advances in …, 2012 - Wiley Online Library
The characteristics of HIV‐associated ITP were documented prior to the HAART era, and the
optimal treatment beyond HAART is unknown. We performed a review of patients with HIV‐…
optimal treatment beyond HAART is unknown. We performed a review of patients with HIV‐…
Comparison of the Villalta post‐thrombotic syndrome score in the ipsilateral vs. contralateral leg after a first unprovoked deep vein thrombosis
…, A Perrier, RH White, LM Vickars… - … of Thrombosis and …, 2012 - Wiley Online Library
Background: Post‐thrombotic syndrome (PTS) is the most frequent complication of a deep
vein thrombosis (DVT). International guidelines recommend assessing PTS with the Villalta …
vein thrombosis (DVT). International guidelines recommend assessing PTS with the Villalta …
Aplastic anemia following administration of a tumor necrosis factor‐α inhibitor
J Kuruvilla, HA Leitch, LM Vickars… - European journal of …, 2003 - Wiley Online Library
Upregulation of tumor necrosis factor‐alpha (TNF‐α) has been implicated in the pathogenesis
of several inflammatory conditions, including rheumatoid arthritis. Therapeutic agents …
of several inflammatory conditions, including rheumatoid arthritis. Therapeutic agents …
Improved survival in patients with myelodysplastic syndrome receiving iron chelation therapy
…, MD Rollins, MJ Barnett, PF Galbraith, LM Vickars - Clinical Leukemia, 2008 - Elsevier
Purpose Patients with myelodysplastic syndrome (MDS) and iron overload (IOL) often receive
iron chelation therapy (ICT); however, data on clinical outcomes are limited. We reviewed …
iron chelation therapy (ICT); however, data on clinical outcomes are limited. We reviewed …
Improved outcome of human immunodeficiency virus-associated plasmablastic lymphoma of the oral cavity in the era of highly active antiretroviral therapy: a report of …
…, RD Gascoyne, PF Galbraith, LM Vickars… - Leukemia & …, 2004 - Taylor & Francis
Plasmablastic lymphoma (PBL) is a recently described type of non-Hodgkin’s lymphoma (NHL)
that occurs in up to 3% of patients with HIV infection. Although the clinical-pathological …
that occurs in up to 3% of patients with HIV infection. Although the clinical-pathological …
Improved survival in red blood cell transfusion dependent patients with primary myelofibrosis (PMF) receiving iron chelation therapy
…, MJ Barnett, LM Foltz, LM Vickars - Hematological …, 2010 - Wiley Online Library
Many patients with primary myelofibrosis (PMF) become red blood cell (RBC) transfusion
dependent (TD), risking iron overload (IOL). Iron chelation therapy (ICT) may decrease the risk …
dependent (TD), risking iron overload (IOL). Iron chelation therapy (ICT) may decrease the risk …
High incidence of extramedullary relapse of AML after busulfan/cyclophosphamide conditioning and allogeneic stem cell transplantation
…, DE Horsman, SH Nantel, LM Vickars… - Bone marrow …, 1998 - nature.com
While allogeneic stem cell transplantation (SCT) is curative for a significant number of patients
with AML, relapse of disease within the bone marrow and/or extramedullary (EM) sites …
with AML, relapse of disease within the bone marrow and/or extramedullary (EM) sites …
